title: [Management of excreta from elderly treated with antineoplastic drugs].
abstract: The excreta management of elderly patients treated by chemotherapy is not regularly dealt by a pragmatic process depending cancer treatments. It involves identifying the excreta toxicity, including their chemical classification, cytotoxic nature, renal or fecal exposition time of the drugs. Protective measures must be described to avoid the risk of contact with potentially contaminated excreta by anticancer drugs or their metabolites. To reduce the risk, information and training are essential. Medical monitoring professionals must be specific. The information must be extended to the patient and his entourage.
authors.affiliation: AP-HP, hôpital Jean-Verdier, gestion des risques, avenue du 14-Juillet, 93140 Bondy, France.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Leduc-Souville
authors.affiliation: AP-HP, hôpital Jean-Verdier, service de pharmacie, avenue du 14-Juillet, 93140 Bondy, France. Electronic address: joel.schlatter@jvr.aphp.fr.
authors.forename: Joël
authors.initials: J
authors.lastname: Schlatter
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001826:Body Fluids; D005243:Feces; D006801:Humans; D012037:Refuse Disposal; D014556:Urine
chemical_list: D000970:Antineoplastic Agents